自动化辅助生殖实验室系统的引入会使大多数胚胎学家变得冗余吗
该文讨论辅助生殖技术(ART)实验室自动化趋势,指出电子见证和胚胎植入潜能排序已应用自动化,未来配子操作、胚胎培养与选择可能由微流控和人工智能完成,胚胎学家任务将减少,但会出现数据采集、管理与分析等新职能及研究技能和沟通需求。
要点
- 电子见证和胚胎植入潜能排序已在IVF实验室应用自动化。
- 未来配子操作可能不再手工,胚胎培养与选择或由微流控和人工智能完成。
- 胚胎学家任务将减少,但数据采集管理分析等新职能将出现。
核心结论
- 胚胎学家任务将不可避免地减少,但会出现数据采集、管理与分析相关新职能及其他研究技能和与同行及患者沟通的增加。
研究设计与样本
- 原文为观点性文章,未报告系统检索范围或样本量。
主要发现
- 电子见证和根据胚胎植入潜能进行排序已在IVF实验室应用自动化。
- 预期不久的将来IVF实验室多种系统将自动化,配子操作将不再手工,胚胎培养和选择将通过微流控和人工智能进行。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IVF techniques have changed over time with the aim of improving clinical results. Today, embryology is facing a change common to most areas of medicine, the introduction of automation. The use of automated systems in the IVF laboratory is already happening, for example, with electronic witnessing and the ranking of embryos according to their implantation potential. It is expected that in the near future, various systems in the IVF laboratory will be automated. In this way, gamete manipulation would cease to be manual and embryo culture and selection would be performed by means of microfluidics and artificial intelligence. Therefore, the tasks of the embryologist will inevitably be reduced. However, new functions related to data capture, management and analysis will emerge, along with other research skills and increased communication with other professionals and patients.
引用
- Bori L, Meseguer M. Will the introduction of automated ART laboratory systems render the majority of embryologists redundant? Reprod Biomed Online. 2021. PMID: 34753681. doi:10.1016/j.rbmo.2021.10.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。